Get startedLog in
    Picture of Solara Active Pharma Sciences logo

    SOLARA — Solara Active Pharma Sciences News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Solara Active Pharma Sciences Gets European Approval To Manufacture Ibuprofen From Vizag Facility

    Picture of Solara Active Pharma Sciences logoSolara Active Pharma Sciences
    01/11/2022 05:09
    Nov 1 (Reuters) - Solara Active Pharma Sciences Ltd
 SOLA.NS :    
    * GETS EUROPEAN APPROVAL TO MANUFACTURE IBUPROFEN FROM VIZAG
FACILITY
    * EXPECTS SERIES OF OTHER INTERNATIONAL REGULATORY APPROVALS
FOR
VIZAG FACILITY, INCLUDING FDA

Source text for Eikon:  ID:nNSE6fJhM4 
Further company coverage:  SOLA.NS 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Solara Active Pharma Sciences

    See all news